Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody ; day:17 ; month:8 ; year:2017 ; pages:1-12
Cancer immunology immunotherapy ; (17.8.2017), 1-12
- Keyword
-
Krebs
Onkologie
- Creator
-
Muthumani, Kar
- Contributor
-
Marnin, Liron
Kudchodkar, Sagar B.
Perales-Puchalt, Alfredo
Choi, Hyeree
Agarwal, Sangya
Scott, Veronica L.
Reuschel, Emma L.
Zaidi, Faraz I.
Duperret, Elizabeth K.
Wise, Megan C.
Kraynyak, Kimberly A.
Ugen, Kenneth. E.
Sardesai, Niranjan Y.
Joseph Kim, J.
Weiner, David B.
SpringerLink (Online service)
- DOI
-
10.1007/s00262-017-2042-7
- URN
-
urn:nbn:de:1111-201710309097
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Muthumani, Kar
- Marnin, Liron
- Kudchodkar, Sagar B.
- Perales-Puchalt, Alfredo
- Choi, Hyeree
- Agarwal, Sangya
- Scott, Veronica L.
- Reuschel, Emma L.
- Zaidi, Faraz I.
- Duperret, Elizabeth K.
- Wise, Megan C.
- Kraynyak, Kimberly A.
- Ugen, Kenneth. E.
- Sardesai, Niranjan Y.
- Joseph Kim, J.
- Weiner, David B.
- SpringerLink (Online service)
Other Objects (12)
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression
Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Monoclonal antibody therapy
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression
Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Monoclonal antibody therapy
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy
CpG-DNA : a potential adjuvant in prostate cancer immunotherapy
Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
Trpv6 channel targeting using monoclonal antibody induces prostate cancer cell apoptosis and tumor regression
Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Monoclonal antibody therapy
Immunotherapy of Prostate Carcinoma with biodegradable PLGA Microspheres
Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy